Clinical Trials

New Search
Title   Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (OPUS)
Disease/Condition   Neurology,Epilepsy
Eligibility Criteria   Click here for eligibility requirements
Principal┬áInvestigator   Alexis Boro, MD
Contact┬áName   Darlene Rozon
Contact Email   drozon@montefiore.org
IRB/Protocol┬áNumber   17-02-374-01
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No